GSA Capital Partners LLP Invests $1.77 Million in Quanterix Corporation $QTRX

GSA Capital Partners LLP purchased a new position in Quanterix Corporation (NASDAQ:QTRX) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 410,252 shares of the company’s stock, valued at approximately $1,772,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Farther Finance Advisors LLC bought a new position in Quanterix during the 4th quarter worth $26,000. Caitong International Asset Management Co. Ltd bought a new stake in Quanterix in the fourth quarter valued at $27,000. Quarry LP lifted its stake in Quanterix by 277,300.0% in the third quarter. Quarry LP now owns 5,548 shares of the company’s stock valued at $30,000 after buying an additional 5,546 shares during the last quarter. AXQ Capital LP bought a new stake in Quanterix in the fourth quarter valued at $70,000. Finally, Renaissance Technologies LLC acquired a new position in shares of Quanterix during the fourth quarter valued at $75,000. Institutional investors and hedge funds own 86.48% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Quanterix in a research report on Friday, August 7th. Wall Street Zen downgraded shares of Quanterix from a “hold” rating to a “sell” rating in a research report on Saturday. TD Cowen reduced their target price on shares of Quanterix from $4.00 to $3.00 and set a “hold” rating for the company in a research note on Tuesday, August 11th. Finally, Canaccord Genuity Group decreased their target price on shares of Quanterix from $8.00 to $4.00 and set a “hold” rating for the company in a research report on Monday, April 20th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Quanterix currently has an average rating of “Reduce” and a consensus price target of $3.50.

Quanterix Price Performance

Shares of Quanterix stock opened at $2.59 on Monday. The business’s fifty day moving average price is $3.62 and its two-hundred day moving average price is $4.06. The company has a market capitalization of $122.48 million, a P/E ratio of -0.98 and a beta of 1.07. Quanterix Corporation has a 1-year low of $2.15 and a 1-year high of $8.77.

Quanterix (NASDAQ:QTRX) last released its quarterly earnings results on Monday, August 10th. The company reported ($1.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.63). The business had revenue of $32.91 million during the quarter, compared to the consensus estimate of $37.48 million. Quanterix had a negative return on equity of 26.09% and a negative net margin of 80.25%.

Quanterix Company Profile

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.